Kaposi, 1872, Arch Derm Syph, 4, 742
Taylor, 1971, Int J Cancer, 8, 122, 10.1002/ijc.2910080116
Hiesse, 1995, Transplant Proc, 27, 972
Friedman-Kien, 1981, J Am Acad Dermatol, 5, 468, 10.1016/S0190-9622(81)80010-2
Beral, 1990, Lancet, 335, 123, 10.1016/0140-6736(90)90001-L
Miles, 1994, Curr Opin Oncol, 6, 497, 10.1097/00001622-199409000-00009
Armes, 1989, Adv Cancer, 53, 73, 10.1016/S0065-230X(08)60279-1
Ensoli, 1991, Hematol Oncol Clin North Am, 5, 281, 10.1016/S0889-8588(18)30441-6
Sturzl, 1992, AIDS Res Hum Retroviruses, 8, 1753, 10.1089/aid.1992.8.1753
Gill, 1991, Curr Opin Oncol, 3, 867, 10.1097/00001622-199110000-00010
Ensoli, 1992, Immunol Rev, 127, 147, 10.1111/j.1600-065X.1992.tb01412.x
Williams, 1995, Hum Pathol, 26, 469, 10.1016/0046-8177(95)90241-4
Hengge, 2002, Lancet Infect Dis, 2, 344, 10.1016/S1473-3099(02)00288-8
Albini, 1995, Proc Natl Acad Sci U S A, 2392, 4838, 10.1073/pnas.92.11.4838
Ensoli, 1994, Nature, 371, 674, 10.1038/371674a0
Maitra, 1994, Virology, 204, 823, 10.1006/viro.1994.1601
Miles, 1992, Curr Opin Oncol, 4, 875, 10.1097/00001622-199210000-00010
Chang, 1994, Science, 267, 1078
Goebel, 1999, Eur J Med Res, 4, 507
Zong, 2002, J Clin Virol, 23, 119, 10.1016/S1386-6532(01)00205-0
Moore, 1996, J Virol, 70, 549, 10.1128/JVI.70.1.549-558.1996
Sarid, 1997, Nat Med, 3, 293, 10.1038/nm0397-293
Bais, 1998, Nature, 391, 86, 10.1038/34193
Kedes, 1996, Nat Med, 2, 918, 10.1038/nm0896-918
Simpson, 1996, Lancet, 346, 1133, 10.1016/S0140-6736(96)07560-5
Whitby, 1995, Lancet, 346, 799, 10.1016/S0140-6736(95)91619-9
Gao, 1996, N Engl J Med, 335, 233, 10.1056/NEJM199607253350403
Martin, 1998, N Engl J Med, 338, 948, 10.1056/NEJM199804023381403
Oksenhendler, 1998, N Engl J Med, 338, 1585, 10.1056/NEJM199805283382204
Ziegler, 1996, Int J Cancer, 65, 200, 10.1002/(SICI)1097-0215(19960117)65:2<200::AID-IJC12>3.0.CO;2-H
Wabinga, 1993, Int J Cancer, 54, 26, 10.1002/ijc.2910540106
Jones, 1999, J Acquir Immune Defic Syndr, 21, S11
Sitas, 2001, J Natl Cancer Inst, 28, 1
Purvis, 1997, J Infect Dis, 175, 947, 10.1086/513997
Hermans, 1998, Biomed Pharmacother, 52, 440, 10.1016/S0753-3322(99)80022-5
Ensoli, 1991, Hematol Oncol Clin North Am, 5, 281, 10.1016/S0889-8588(18)30441-6
Hermans, 1994, Br J Haematol, 345, 84
Wang, 1995, Mayo Clin Proc, 70, 869, 10.1016/S0025-6196(11)63945-1
Samaniego, 1995, J Immunol, 154, 3582, 10.4049/jimmunol.154.7.3582
Neipel, 1997, J Virol, 71, 4187, 10.1128/JVI.71.6.4187-4192.1997
Albrecht, 1992, J Virol, 66, 5047, 10.1128/JVI.66.8.5047-5058.1992
Neipel, 1997, J Virol, 71, 839, 10.1128/JVI.71.1.839-842.1997
Sun, 1999, J Virol, 73, 2232, 10.1128/JVI.73.3.2232-2242.1999
Moore, 1996, Science, 274, 1739, 10.1126/science.274.5293.1739
Renne, 2001, J Virol, 75, 458, 10.1128/JVI.75.1.458-468.2001
Dupin, 1999, Proc Natl Acad Sci U S A, 96, 4546, 10.1073/pnas.96.8.4546
Radkov, 2000, Nat Med, 6, 1121, 10.1038/80459
Monini, 1999, Blood, 93, 4044
Jones, 1999, Blood, 94, 2871, 10.1182/blood.V94.8.2871
Chang, 2000, Virology, 266, 17, 10.1006/viro.1999.0077
Russo, 1996, Proc Natl Acad Sci U S A, 93, 14862, 10.1073/pnas.93.25.14862
Cesarman, 1996, J Virol, 70, 8218, 10.1128/JVI.70.11.8218-8223.1996
Arvanitakis, 1997, Nature, 385, 347, 10.1038/385347a0
Lee, 1998, Nat Med, 4, 435, 10.1038/nm0498-435
Osborne, 1999, Hum Immunol, 60, 921, 10.1016/S0198-8859(99)00083-X
Bais, 1998, Nature, 391, 86, 10.1038/34193
Yang, 2000, J Exp Med, 191, 445, 10.1084/jem.191.3.445
Cheng, 1997, Proc Natl Acad Sci U S A, 94, 690, 10.1073/pnas.94.2.690
Sarid, 1997, Nat Med, 3, 293, 10.1038/nm0397-293
Cannon, 2000, Semin Oncol, 27, 409
Thome, 1997, Nature, 386, 517, 10.1038/386517a0
Hengge, 2002, Lancet Infect Dis, 2, 281, 10.1016/S1473-3099(02)00263-3
Krown, 1983, N Engl J Med, 308, 1071, 10.1056/NEJM198305053081806
Baca-Regen, 1994, J Virol, 68, 7559, 10.1128/JVI.68.11.7559-7565.1994
Ho, 1985, Lancet, I, 602, 10.1016/S0140-6736(85)92144-0
Evans, 1991, J Immunother, 10, 39, 10.1097/00002371-199102000-00006
Real, 1986, J Clin Oncol, 4, 544, 10.1200/JCO.1986.4.4.544
Krown, 1984, Ann N Y Acad Sci, 437, 431, 10.1111/j.1749-6632.1984.tb37164.x
Gelmann, 1985, Am J Med, 78, 737, 10.1016/0002-9343(85)90276-1
Vadhan-Raj, 1986, Cancer Res, 46, 417
Mildvan, 1996, Antiviral Ther, 1, 77
Krown, 1991, J Acquir Immune Defic Syndr, 4, 871, 10.1097/00126334-199109000-00008
Mildvan, 1992, Lancet, 339, 453, 10.1016/0140-6736(92)91058-G
Shepherd, 1998, J Clin Oncol, 16, 1736, 10.1200/JCO.1998.16.5.1736
Krown, 1990, Ann Intern Med, 112, 812, 10.7326/0003-4819-112-11-812
Levine, 2001, Eur J Cancer, 37, 1288, 10.1016/S0959-8049(01)00109-5
Mauss, 1995, J Acquir Immune Defic Syndr, 2, 157, 10.1097/00042560-199510020-00007
Hess, 1991, Infection, 19, 93, 10.1007/BF01644475
Rossol, 1989, J Infect Dis, 159, 815, 10.1093/infdis/159.5.815
Lau, 1989, J Clin Invest, 84, 738, 10.1172/JCI114231
Poli, 1994, Antiviral Res, 24, 221, 10.1016/0166-3542(94)90069-8
Schroder, 1992, Nachr Chem Tech Lab, 40, 1352, 10.1002/nadc.19920401205
Cohen, 1991, Cytokine, 3, 83, 10.1016/1043-4666(91)90027-B
Von Wussow, 1990, Eur J Immunol, 20, 2015, 10.1002/eji.1830200920
Jakschies, 1994, Hepatology, 19, 857
Antinori, 1992, J Cancer Res Clin Oncol, 118, 635, 10.1007/BF01211811
Krown, 1989, J Clin Oncol, 7, 1201, 10.1200/JCO.1989.7.9.1201
Francis, 1986, J Clin Pathol, 39, 469, 10.1136/jcp.39.5.469
2000, Lancet, 355, 1131, 10.1016/S0140-6736(00)02061-4
Hengge, 2001, Eur J Cancer, 37, 878, 10.1016/S0959-8049(01)00053-3
Hortobagyi, 1997, Drugs, 54, 1, 10.2165/00003495-199700544-00003
Hengge, 1993, Lancet, 342, 497, 10.1016/0140-6736(93)91624-U
Lasic, 1996, Nature, 380, 561, 10.1038/380561a0
Martin, 1996, DOXIL Clinical Series, 1, 1
Gabizon, 1994, Cancer Res, 54, 987
Northfelt, 1996, J Clin Pharmacol, 36, 55, 10.1002/j.1552-4604.1996.tb04152.x
Stewart, 1998, J Clin Oncol, 16, 683, 10.1200/JCO.1998.16.2.683
Northfelt, 1998, J Clin Oncol, 16, 2445, 10.1200/JCO.1998.16.7.2445
Gill, 1996, J Clin Oncol, 14, 2353, 10.1200/JCO.1996.14.8.2353
Rosenthal, 2002, Am J Clin Oncol, 25, 2353, 10.1097/00000421-200202000-00012
Tulpule, 1998, J Clin Oncol, 16, 3369, 10.1200/JCO.1998.16.10.3369
Bennett, 1998, J Acquir Immune Defic Syndr Hum Retrovirus, 18, 460, 10.1097/00042560-199808150-00007
Osoba, 2001, Cancer Invest, 19, 573, 10.1081/CNV-100104284
Hengge, 1993, Lancet, 341, 383, 10.1016/0140-6736(93)90198-P
Gill, 1999, J Clin Oncol, 17, 1876, 10.1200/JCO.1999.17.6.1876
Welles, 1998, J Clin Oncol, 16, 1112, 10.1200/JCO.1998.16.3.1112
Tulpule, 2002, Cancer, 95, 147, 10.1002/cncr.10634
Aboulafia, 2003, Arch Dermatol, 139, 178, 10.1001/archderm.139.2.178
Bernstein, 2002, Cancer, 95, 2555, 10.1002/cncr.11009
Ledergerber, 1999, BJM, 319, 23, 10.1136/bmj.319.7201.23
Murphy, 1997, AIDS, 11, 261
Aboulafia, 1998, Mayo Clin Proc, 73, 439, 10.1016/S0025-6196(11)63726-9
Levine, 2001, Eur J Cancer, 37, 1288, 10.1016/S0959-8049(01)00109-5
Cattelan, 2001, J Natl Cancer Inst Monogr, 28, 44
Boivin, 2000, AIDS, 14, 1907, 10.1097/00002030-200009080-00004
Strickler, 1999, J Infect Dis, 180, 1682, 10.1086/315056
Gill, 2002, J Acquir Immune Defic Syndr, 31, 384, 10.1097/00126334-200212010-00003
Esdaile, 2002, AIDS, 16, 2344, 10.1097/00002030-200211220-00019
Toschi, 2002, Anticancer Drugs, 13, 977, 10.1097/00001813-200211000-00001
Kedes, 1997, J Clin Invest, 99, 2082, 10.1172/JCI119380
Robles, 1999, J Acquir Immune Defic Syndr Hum Retrovirol, 20, 34, 10.1097/00042560-199901010-00005
Martin, 1999, N Engl J Med, 340, 1063, 10.1056/NEJM199904083401402
Cordero, 1997, AIDS, 11, 1787
Hammoud, 1998, Clin Infect Dis, 26, 1233, 10.1086/598351
Little, 1998, J Infect Dis, 187, 149, 10.1086/346159
Tappero, 1991, J Acquir Immune Defic Syndr, 4, 839, 10.1097/00126334-199109000-00002
Brenner, 1999, Int J Oncol, 14, 1097
Holecek, 1978, Cancer, 41, 1733, 10.1002/1097-0142(197805)41:5<1733::AID-CNCR2820410513>3.0.CO;2-S
1986, Arch Dermatol, 122, 1396, 10.1001/archderm.1986.01660240060016
Groopman, 1985, Front Radiat Ther Oncol, 19, 126, 10.1159/000429353
Nisce, 1981, Cancer, 47, 640, 10.1002/1097-0142(19810215)47:4<640::AID-CNCR2820470403>3.0.CO;2-S
Berson, 1990, Int J Radiat Oncol Biol Phys, 19, 569, 10.1016/0360-3016(90)90482-Y
de Wit, 1990, Radiother Oncol, 19, 131, 10.1016/0167-8140(90)90126-H
Stelzer, 1993, Int J Radiat Oncol Biol Phys, 27, 1057, 10.1016/0360-3016(93)90523-X
Watkins, 1987, Int J Radiat Oncol Biol Phys, 13, 1403, 10.1016/0360-3016(87)90237-9
Schweitzer, 1990, Otolaryngol Head Neck Surg, 102, 639, 10.1177/019459989010200603
Marchell, 1997, Dermatol Surg, 23, 973
Epstein, 1989, Cancer, 64, 2424, 10.1002/1097-0142(19891215)64:12<2424::AID-CNCR2820641205>3.0.CO;2-X
Boudreaux, 1993, J Am Acad Dermatol, 28, 61, 10.1016/0190-9622(93)70010-Q
Walmsley, 1999, J Acquir Immune Defic Syndr, 22, 235, 10.1097/00042560-199911010-00004
Bodsworth, 2001, Am J Clin Dermatol, 2, 77, 10.2165/00128071-200102020-00004
Tossing, 2001, Eur J Med Res, 6, 47
Tossing, 2001, nfection, 29, 1, 10.1007/s15010-001-1181-z
Hatzakis, 2001, J Interferon Cytokine Res, 21, 861, 10.1089/107999001753238114
Emilie, 2001, AIDS, 15, 1435, 10.1097/00002030-200107270-00014
DAmato, 1994, Proc Natl Acad Sci U S A, 91, 4082, 10.1073/pnas.91.9.4082
Thomas, 2000, Curr Opin Oncol, 12, 564, 10.1097/00001622-200011000-00009
Fife, 1998, Int J STD AIDS, 9, 751, 10.1258/0956462981921512
Politi, 1998, Proc Am Soc Clin Oncol, 17, 45
Little, 2000, J Clin Oncol, 18, 2593, 10.1200/JCO.2000.18.13.2593
Millauer, 1993, Cell, 72, 835, 10.1016/0092-8674(93)90573-9
Millauer, 1994, Nature, 367, 576, 10.1038/367576a0
Fong, 1999, Cancer Res, 59, 99
Miles, 2000, Proc Am Soc Clin Oncol, 19, 176a
Via, 2000, Oncology, 14, 1312
Mesters, 2001, Blood, 98, 241, 10.1182/blood.V98.1.241
Tulpule, 2000, J Clin Oncol, 18, 716, 10.1200/JCO.2000.18.4.716
Dezube, 1998, J Clin Oncol, 16, 1444, 10.1200/JCO.1998.16.4.1444
Sternlicht, 2000, Emerging Ther Targets, 4, 609, 10.1517/14728222.4.5.609
Rader, 2002, FASEB J, 16, 2000, 10.1096/fj.02-0281fje
